- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 295/30 - Atomes d'azote non acylés
Détention brevets de la classe C07D 295/30
Brevets de cette classe: 36
Historique des publications depuis 10 ans
|
4
|
5
|
3
|
2
|
0
|
1
|
0
|
1
|
3
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Axolabs GmbH | 15 |
4 |
| The Trustees of Columbia University in the City of New York | 3529 |
3 |
| Abbvie Inc. | 1789 |
3 |
| Sutter Bay Hospitals | 15 |
3 |
| Centre National de La Recherche Scientifique | 10158 |
2 |
| St. Mary's University | 10 |
2 |
| Universite de Montpellier | 962 |
2 |
| Janssen Pharmaceutica N.V. | 3606 |
1 |
| Apogee Biotechnology Corporation | 16 |
1 |
| Arizona Board of Regents on behalf of Arizona State University | 2484 |
1 |
| Cambrex Karlskoga AB | 17 |
1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 676 |
1 |
| Innovascreen Inc. | 4 |
1 |
| Lantheus Medical Imaging, Inc. | 172 |
1 |
| Murdoch University | 71 |
1 |
| Pharmos Corporation | 4 |
1 |
| Reuter Chemische Apparatebau KG | 15 |
1 |
| Suven Life Sciences Limited | 129 |
1 |
| Synta Pharmaceuticals Corp. | 188 |
1 |
| The United States Government AS represented by The Department of Veterans Affairs | 1110 |
1 |
| Autres propriétaires | 4 |